找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cytokine Frontiers; Regulation of Immune Takayuki Yoshimoto,Tomohiro Yoshimoto Book 2014 Springer Japan 2014 Anti-inflammatory cytokines.Pr

[复制链接]
楼主: 适婚女孩
发表于 2025-3-28 18:27:11 | 显示全部楼层
S. Lustig,P. Schramel,Ph. Quevauvillery disease models and has been recently shown to have additional functions aside from inhibition of proliferation, including inducing its own expression in non-Treg cells. In this chapter, we discuss the history and current status of IL-35 biology, as well as suggest where the field might move in the future.
发表于 2025-3-28 19:53:18 | 显示全部楼层
发表于 2025-3-28 22:58:35 | 显示全部楼层
Lóránt Dávid,Zoltán Ilyés,Zoltán Barosmune response to a pathogen which could result in chronic infection. Regulation of the immune response by IL-10 has been shown to play a role in control of allergic, inflammatory, and autoimmune diseases, and further knowledge may advance our ability to use antagonists or agonists of IL-10 for immune therapies.
发表于 2025-3-29 06:59:54 | 显示全部楼层
C. Dietl,D. Laschka,M. Wäber,L. Peichlity against a variety of mouse and human tumors and suppresses the development of inflammatory, allergic, and autoimmune diseases. In this chapter, we review the molecular characterization of IL-27 and its receptor, its pro- and anti-inflammatory properties, and the therapeutic implications.
发表于 2025-3-29 10:05:07 | 显示全部楼层
发表于 2025-3-29 13:57:19 | 显示全部楼层
Interleukin-10: Cytokines in Anti-inflammation and Tolerancemune response to a pathogen which could result in chronic infection. Regulation of the immune response by IL-10 has been shown to play a role in control of allergic, inflammatory, and autoimmune diseases, and further knowledge may advance our ability to use antagonists or agonists of IL-10 for immune therapies.
发表于 2025-3-29 17:27:31 | 显示全部楼层
发表于 2025-3-29 19:48:52 | 显示全部楼层
发表于 2025-3-30 03:17:47 | 显示全部楼层
The Interleukin-1 Familyne is present in most cells and readily released upon cell death. Although treatment for autoimmune diseases often includes immunosuppressive drugs, blocking the IL-1 receptor is effective as an anti-inflammatory therapy for either IL-1α or IL-1β.
发表于 2025-3-30 07:16:15 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-5 22:00
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表